Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2004-09-17
2008-08-05
Carlson, Karen Cochrane (Department: 1656)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C536S023100, C530S350000
Reexamination Certificate
active
07407776
ABSTRACT:
Disclosed herein are methods and compositions for modulation of gene expression, with single-gene specificity, in a human-sized genome.
REFERENCES:
patent: 4186183 (1980-01-01), Steck et al.
patent: 4217344 (1980-08-01), Vanlerberghe et al.
patent: 4235871 (1980-11-01), Papahadjopolous et al.
patent: 4261975 (1981-04-01), Fullerton et al.
patent: 4485054 (1984-11-01), Mezei et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4603044 (1986-07-01), Geho et al.
patent: 4774085 (1988-09-01), Fidler
patent: 4797368 (1989-01-01), Carter et al.
patent: 4837028 (1989-06-01), Allen
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 4946787 (1990-08-01), Eppstein et al.
patent: 4957773 (1990-09-01), Spencer et al.
patent: 5049386 (1991-09-01), Eppstein et al.
patent: 5173414 (1992-12-01), Lebkowski et al.
patent: 5176996 (1993-01-01), Hogan et al.
patent: 5272071 (1993-12-01), Chappel
patent: 5356802 (1994-10-01), Chandrasegaran
patent: 5364791 (1994-11-01), Vegeto et al.
patent: 5422251 (1995-06-01), Fresco
patent: 5436150 (1995-07-01), Chandrasegaran
patent: 5487994 (1996-01-01), Chandrasegaran
patent: 5585245 (1996-12-01), Nils et al.
patent: 5789538 (1998-08-01), Rebar et al.
patent: 5792640 (1998-08-01), Chandresegaran
patent: 5834266 (1998-11-01), Crabtree et al.
patent: 5874534 (1999-02-01), Vegeto et al.
patent: 5916794 (1999-06-01), Chandresegaran
patent: 5925523 (1999-07-01), Dove et al.
patent: 5935934 (1999-08-01), Vegeto et al.
patent: 5994313 (1999-11-01), Crabtree et al.
patent: 6007988 (1999-12-01), Choo et al.
patent: 6013453 (2000-01-01), Choo et al.
patent: 6140081 (2000-10-01), Barbas
patent: 6200759 (2001-03-01), Dove et al.
patent: 6265196 (2001-07-01), Chandrasegeren
patent: 6270990 (2001-08-01), Anderson et al.
patent: 6453242 (2002-09-01), Eisenberg et al.
patent: 6534261 (2003-03-01), Cox et al.
patent: 6607882 (2003-08-01), Cox et al.
patent: WO 91/16024 (1991-10-01), None
patent: WO 91/17424 (1991-11-01), None
patent: WO 93/24641 (1993-02-01), None
patent: WO 94/18313 (1994-08-01), None
patent: WO 94/26877 (1994-11-01), None
patent: WO 95/19431 (1995-07-01), None
patent: WO 96/06166 (1996-02-01), None
patent: WO 98/44350 (1998-10-01), None
patent: WO 98/53057 (1998-11-01), None
patent: WO 98/53058 (1998-11-01), None
patent: WO 98/53059 (1998-11-01), None
patent: WO 98/53060 (1998-11-01), None
patent: WO 98/54311 (1998-12-01), None
patent: WO 99/10508 (1999-03-01), None
patent: WO 99/27092 (1999-06-01), None
patent: WO 00/27878 (2000-05-01), None
patent: WO 01/04296 (2001-01-01), None
patent: WO 01/53480 (2001-07-01), None
patent: WO 01/60970 (2001-08-01), None
patent: WO 01/83793 (2001-11-01), None
patent: WO 01/88197 (2001-11-01), None
patent: WO 02/26959 (2002-04-01), None
patent: WO 02/26960 (2002-04-01), None
patent: WO 02/44376 (2002-06-01), None
patent: WO 02/44386 (2002-06-01), None
patent: WO 02/077227 (2002-10-01), None
patent: WO 02/099084 (2002-12-01), None
patent: WO 03/016496 (2003-02-01), None
patent: WO 03/087341 (2003-10-01), None
patent: WO 2005/014791 (2005-02-01), None
patent: WO 2005/116060 (2005-12-01), None
Ahmad et al., “Antibody-Medicated Specific Binding and Cytotoxicity of Liposome-Entrapped Doxorubicin to Lung Cancer Cells In Vitro,” Cancer Res 52(17):4817-4820 (1992).
Ahn et al., “Threonine 68 Phosphorylation by Ataxia Telangiectasia Mutated is Required for Efficient Activation of CHK2 in Response to Ionizing Radiation,” Cancer Res 60:5934-5936 (2000).
Altincicek et al., “Interaction of the Corepressor Alien With DAX-1 is Abrogated by Mutations of DAX-1 Involved in Adrenal Hypoplasia Congenital,” J. Biol. Chem. 275(11):7662-7667 (2000).
Alvarez et al. “A Phase I Study of Recombinant Adenovirus Vector-Mediated Intraperitoneal Delivery of Herpes Simplex Virus Thymidine Kinase (HSV-TK) Gene and Intravenous Ganciclovir for Previously Treated Ovarian and Extraovarian Cancer Patients,” Hum. Gene Ther. 8(5):597-613 (1997).
Anderson, “Human Gene Therapy,” Science 256(5058):808-813 (1992).
Arora et al., “Residues 1-254 of Anthrax Toxin Lethal Factor are Sufficient to Cause Cellular Uptake of Fused Polypeptides,” J. Biol. Chem. 268(5):3334-3341 (1993).
Aso et al., “Transcription Syndromes and the Role of RNA Polymerase II General Transcription Factors in Human Disease,” J. Clin. Invest. 97:1561-1569 (1996).
Ayer et al., “Mad Proteins Contain a Dominant Transcription Repression Domain,” Mol. Cell. Biol. 16(10):5772-5781 (1996).
Ballard et al., “The 65-KDA Subunit of Human NF-{KAPPA}B Functions as a Potent Transcriptional Activator and a Target for V-Rel-Mediated Repression,” PNAS USA 89:1875-1879 (1992).
Barahmand-Pour et al., “A Role for Stat Family Transcription Factors in Myeloid Differentiation,” Curr Top Microbiol Immunol 211:121-128 (1996).
Barnes & Adcock “Transcription Factors,” Clin Exp Allergy 2:46-49 (1995).
Bartek et al., “CHK2 Kinase—A Busy Messenger,” Nat Rev Mol Cell Biol 2:877-886 (2001).
Bartsevich et al., “Regulation of the MDRI Gene by Transcriptional Repressors Selected Using Peptide Combinatorial Libraries,” Mol Pharmacol 58:1-10 (2000).
Batzer et al., “Enhanced Evolutionary PCR Using Oligonucleotides With Inosine at the 3′—Terminus,” Nucleic Acid Res. 19:5081 (1991).
Beerli et al., “Positive and Negative Regulation of Endogenous Genes by Designed Transcription Factors,” PNAS 97: 1495-1500 (2000).
Behr et al., “Gene Transfer With Synthetic Cationic Amphiphiles: Prospects for Gene Therapy,” Bioconjug. Chem. 5(5):382-389 (1994).
Berg et al., “The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc,” Science 271: 1081-1085 (1996).
Beug et al., “Avian Erythropoiesis and Erythroleukemia: Towards Understanding the Role of the Biomolecules Involved,” Biochim. Biophys. Acta 1288(3):M35-47 (1996).
Bird et al., “Methylation-Induced Repression—Belts, Braces, and Chromatin,” Cell 99(5):451-454 (1999).
Bitko & Barik, “Persistent Activation of Rela by Respiratory Syncytial Virus Involves Protein Kinase C, Underphosphorylated Ikappabbeta, and Sequestration of Protein Phosphatase 2A by the Viral Phosphoprotein,” J. Virol. 72(7):5610-5618 (1998).
Blaese et al., “Vectors in Cancer Therapy: How Will They Deliver?” Cancer Gene Therapy 2:291-297 (1995).
Blaese et al., “T Lymphocyte-Directed Gene Therapy for ADA- SCID: Initial Trial Results After 4 Years,” Science 270(5235):475-480 (1995).
Boulikas, “Phosphorylation of Transcription Factors and Control of the Cell Cycle,” Crit Rev Eukaryot. Gene Expr. 5(1):1-77 (1995).
Buchscachher et al., “Human Immunodeficiency Virus Vectors for Inducible Expression of Foreign Genes,” J Virol 66(5):2731-2739 (1992).
Burley et al., “The TATA Binding Protein,” Curr. Opin. Struct. Biol. 6:69-75 (1996).
Capecchi et al., “Altering the Genome by Homologous Recombination,” Science 244:1288-1292 (1989).
Carbonetti et al., “Use of Purtussis Toxin Vaccine Molecule PT9K/129G to Deliver Peptide Epitopes for Stimulation of a Cytotoxic T Lymphocyte Response,” Abstr. Annu. Meet. Am. Soc. Microbiol. 95:295 (1995).
Carreira et al., “Brachyury-Related Transcription Factor TBX2 and Repression of the Melanocyte-Specific TRP-1 Promoter,” Mol. Cell. Biol. 18(9):5099-5108 (1998).
Chehab et al., “CHK2/HCDS1 Functions as a DNA Damage Checkpoint in G1 by Stabilizing P53,” Genes Dev 14:278-288 (2000).
Cheng, “DNA Modification by Methyltransferases,” Curr. Opin. Struct. Biol. 5(1):4-10 (1995).
Chern et al., “The Regulator of MAT2 (ROM2) Protein Binds to Early Maturation Promoters and Represses PVALF-Activated Transcription,” Plant Cell 8(2):305-321 (1996).
Cho et al., “Analysis of the C-Terminal Region of Arabidopsis Thaliana Apetalai as
Choo Yen
Klug Aaron
Moore Michael
Carlson Karen Cochrane
Robins & Pasternak LLP
Sangamo Biosciences, Inc.
LandOfFree
Engineered zinc finger proteins for regulation of gene... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Engineered zinc finger proteins for regulation of gene..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Engineered zinc finger proteins for regulation of gene... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4006390